| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis and Lipoproteins |
From the Section of Diabetes, Endocrinology, and Metabolism, Departments of Medicine (P.P.L., L.C.) and Molecular and Cellular Biology (L.L., A.J.M., A.L.Z., K.W.S.K., L.C.), Baylor College of Medicine, and St. Lukes Episcopal Hospital (L.C.), Houston, Texas.
Correspondence to Lawrence Chan, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. E-mail lchan{at}bcm.tmc.edu
Objective We investigated the molecular mechanism of nicotine-accelerated atherosclerosis in a hyperlipidemic low-density lipoprotein receptor/ mouse model.
Methods and Results Low-density lipoprotein receptor/ mice received time-release nicotine or placebo pellets for 90 days. Aortic lesion size was 2.5 times larger in nicotine-treated than in placebo-treated mice (P<0.001). A mild increase in lipids was seen in treated mice. We quantified 18 different serum cytokines and found a significant increase of tumor necrosis factor
, interleukin 1ß, and keratinocyte-derived chemokine in nicotine-treated mice. Among 107 nuclear factor
B (NF-
B) target genes screened from the aorta, we found that nicotine treatment upregulated only 4 atherogenic genes including vascular adhesion molecule 1 and cyclooxygenase 2 on day 60 and platelet-derived growth factor B and platelet 12-lipoxygenase on day 90. At the cellular level, nicotine induced tumor necrosis factor
and inducible nitric oxide synthase expression in RAW264.7 cells via the nicotinic acetylcholine receptors. Induction was confirmed in peritoneal macrophages isolated from nicotine-treated mice. Finally, we showed that preconditioned medium from nicotine-treated RAW264.7 cells activated NF-
B in human smooth muscle cells and vascular endothelial cells as evidenced by nuclear localization and electromobility shift assay.
Conclusions Chronic nicotine exposure augments atherosclerosis by enhancing the production of proinflammatory cytokines by macrophages, which, in turn, activate atherogenic NF-
B target genes in the aortic lesions.
We investigated the molecular mechanism of nicotine-accelerated atherosclerosis in the hyperlipidemic LDLR/ mouse model. Our findings reveal a novel mechanism of nicotine-mediated atherogenesis. Nicotine directly activates macrophages via the nicotinic acetylcholine receptor, activating multiple downstream events, leading to NF-
Bmediated inflammation in the arterial wall and accelerated atherosclerosis.
Key Words: nicotine atherosclerosis inflammation macrophages NF-kB
This article has been cited by other articles:
![]() |
S. S. Barbieri and B. B. Weksler Tobacco smoke cooperates with interleukin-1{beta} to alter {beta}-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo FASEB J, June 1, 2007; 21(8): 1831 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Abbasi, H. M. F. Farin, C. Lamendola, T. McLaughlin, E. A. Schwartz, G. M. Reaven, and P. D. Reaven The Relationship between Plasma Adiponectin Concentration and Insulin Resistance Is Altered in Smokers J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5002 - 5007. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Pandit, L. Sikora, G. Muralidhar, S. P. Rao, and P. Sriramarao Sustained Exposure to Nicotine Leads to Extramedullary Hematopoiesis in the Spleen Stem Cells, November 1, 2006; 24(11): 2373 - 2381. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |